Skip to main content

Table 4 Incidence Rate Ratios (IRRs) for country of birth and invasive breast cancer by ER status

From: Incidence of breast cancer subtypes in immigrant and non-immigrant women in Norway

 

Age 20–75

Age 20–49

ER-

ER + 

ER-

ER + 

Cases

IRR (CI)

Cases

IRR (CI)

Cases

IRR (CI)

Cases

IRR (CI)

Non-immigrants

3282

1.00 (ref)

17,844

1.00 (ref)

959

1.00 (ref)

3645

1.00 (ref)

High-income

94

0.95 (0.78–1.17)

561

1.09 (1.00–1.18)

29

0.85 (0.59–1.23)

120

0.97 (0.81–1.16)

Eastern Europe

66

0.76 (0.60–0.98)

336

0.86 (0.77–0.95)

35

0.73 (0.52–1.03)

155

0.96 (0.82–1.12)

Middle East

23

0.89 (0.59–1.34)

110

0.95 (0.78–1.14)

13

0.85 (0.49–1.47)

55

1.03 (0.79–1.34)

Sub-Saharan Africa

13

0.71 (0.41–1.22)

43

0.57 (0.42–0.77)

12

0.93 (0.53–1.65)

28

0.66 (0.46–0.96)

South Asia

41

1.36 (1.00–1.85)

96

0.67 (0.55–0.82)

16

1.06 (0.65–1.75)

45

0.85 (0.64–1.14)

South-East Asia

31

0.70 (0.49–1.00)

142

0.71 (0.60–0.84)

18

0.70 (0.44–1.11)

79

0.89 (0.71–1.11)

  1. ER; estrogen receptor, IRR; incidence rate ratio, CI; confidence interval, ref; reference, High-income; Western Europe, USA, Canada, Australia and New Zealand, Eastern Europe; Eastern Europe, Baltics and Balkan, Middle East; Middle East and North Africa